sentence-transformers How to use patentory/patentory_model with sentence-transformers:
from sentence_transformers import SentenceTransformer
model = SentenceTransformer("patentory/patentory_model")
sentences = [
"cosmetic and dermatolic compositions containing chitosan and phospholipids [SEP] obtain the subject preparation which can be prescribed into a freely flowable preparation or a creamy preparation, has very good characteristics on makeup with respect to stickiness, has a good skin care performance, and is useful for skin care creams and so on by including specific chitosan and a phospholipid. this preparation contains (a) chitosan having an average mol.wt. of 10,000 to 2,000,000 g/mol and a deacylation degree of 10 to 99%, and (b) one or more kinds of phospholipids (for example, lecithin). the component a especially has an average mol.wt. of 100,000 to 1,000,000 g/mol and a deacylation degree of 55 to 99%. the preparation preferably contains the component a in an amount of 01 to 50 wt.%, especially 25 to 5 wt.%, and the component b in an amount of 001 to 30 wt.%, especially 5 to 5 wt.%, based on the total weight of the preparation. [SEP] cosmetic or dermatological preparations which comprise (a) chitosan of average molecular weight from 100 000 to 1 000 000 g/mol and a degree of deacetylation of from 10 to 99% and (b) one or more phospholipids.",
"variants of human recombinant interferon-.gamma. (rhu-ifn-.gamma.) having increased heat-stability [SEP] the invention concerns variants of recombinant human interferon-.gamma. (rhuifn-.gamma.) having increased heat-stability. proceeding from rhu-ifn-.gamma., at least one of the following amino acid pairs is changed into cysteine in the amino acid sequence of the polypeptide monomer: glu8 and ser70, ala18 and his112, lys81 and leu121, and gln49 and leu96. additionally, the c-terminal end of the polypeptide can be shortened by between 1 and 10 amino acids. the novel proteins according to the invention have greater heat-stability than the unchanged rhu-ifn-.gamma. without any loss in biological activity. the invention further concerns the preparation of the oligonucleotides, vectors and micro-organisms necessary for producing the proteins according to the invention. finally, the invention concerns a process for the preparation of the proteins and uses thereof. [SEP] polypeptide having the following amino acid sequence: wherein xaa and xab, xba and xbb, xca and xcb or xda and xdb in each case designate pairs of amino acids and the amino acids of at least one of these pairs are cysteine in pairs and wherein the following applies for the amino acids which are not cysteine: xaa = glu, xab = ser xab = ala, xbb = his xca = lys, xcb = leu xda = gln, xdb = leu, the variants of same in which the c-terminal end is shortened by 1 to 10 amino acids, and their homodimers.",
"skin care compositions [SEP] the present invention relates to a topical skin care formulation comprised of micronized calcium citrate and salicylic acid. this composition provides a method for treating acne as well as providing for a variety of skin beautification products which are especially applicable to sensitive skin. [SEP] a method for removing soft corns in a human having a skin affected thereby comprising administering topically to the affected skin a therapeutically effective amount of micronized calcium citrate and salicylic acid.",
"biodegradable biocompatible implant and method of manufacturing same [SEP] formulations or delivery systems are provided for controlled release of therapeutically active agents. the delivery systems are composed of polymer and lipid materials and may be prepared as a gel, paste, solution, film, implant or barrier depending on the intended application. the polymer component of the matrix is the naturally occurring biomaterial, chitosan, or a mixture of chitin and chitosan. the lipid component may include phosphatidylcholine, phosphatidylserine, phosphatidylinositol, phosphatidyl or a mixture thereof. the delivery system may be used for delivery of hydrophilic agents, hydrophobic agents or combinations thereof. the therapeutically active agents may be formulated within the matrix as free agents or incorporated into particles. in a preferred embodiment the agents are incorporated into polymeric particles that are dispersed throughout the matrix. [SEP] a drug delivery composition comprising: (a) a phospholipid, (b) a chitosan based material, and (c) at least one pharmaceutically active agent wherein the phospholipid and the chitosan based material form a physically cross-linked matrix for controlled release of the pharmaceutically active agent."
]
embeddings = model.encode(sentences)
similarities = model.similarity(embeddings, embeddings)
print(similarities.shape)
# [4, 4] 
